Bactigram

Active substance

Cefaclor

Strenght and pharmaceutical forms

250 mg/5 ml granules for oral suspension –100ml bottle
500 mg hard capsules – 8 hard capsules
750 mg modified release tablets – 6 tablets

ATC

J01DC04 - Antibiotic for oral use, belonging to the class of cephalosporins

Therapeutic Indications

BACTIGRAM GRANULES FOR ORAL SUSPENSION
BACTIGRAM HARD CAPSULES

Cefaclor is indicated for the treatment of the following infections sustained by susceptible germs:

Respiratory tract infections, including pneumonia, bronchitis, exacerbations of chronic bronchitis, pharyngitis and tonsillitis;
otitis media;
skin and soft tissue infections;
urinary tract infections, including pyelonephritis and cystitis;
sinusitis;
gonococcal urethritis.

BACTIGRAM MODIFIED RELEASE TABLETS

It is indicated for the treatment of the most serious forms of the following infections:

acute bronchitis and exacerbation of chronic bronchitis;
pharyngitis and tonsillitis;
skin and soft tissue infections;
uncomplicated infections of the lower urinary tract.

Marketing Authorization Holder

Magis Farmaceutici S.r.l.

Download area

Summary of Product Characteristics – Bactigram granules for oral suspension and Bactigram hard capsules

Summary of Product Characteristics – Bactigram modified release tablets